SYNDAX PHARMACEUTICALS, INC. AND , AS WARRANT AGENT FORM OF PREFERRED STOCK WARRANT AGREEMENT DATED AS OFPreferred Stock Warrant Agreement • March 24th, 2021 • Syndax Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 24th, 2021 Company Industry JurisdictionTHIS PREFERRED STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between SYNDAX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
SYNDAX PHARMACEUTICALS, INC. AND , AS WARRANT AGENT FORM OF COMMON STOCK WARRANT AGREEMENT DATED AS OFCommon Stock Warrant Agreement • March 24th, 2021 • Syndax Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 24th, 2021 Company Industry JurisdictionTHIS COMMON STOCK WARRANT AGREEMENT (this “Agreement”), dated as of [●], between SYNDAX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [●] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
SYNDAX PHARMACEUTICALS, INC. AND , AS WARRANT AGENT FORM OF DEBT SECURITIES WARRANT AGREEMENT DATED AS OFWarrant Agreement • March 24th, 2021 • Syndax Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 24th, 2021 Company Industry JurisdictionTHIS DEBT SECURITIES WARRANT AGREEMENT (this “Agreement”), dated as of [●], between SYNDAX PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and [●], a [corporation] [national banking association] organized and existing under the laws of [•] and having a corporate trust office in [●], as warrant agent (the “Warrant Agent”).
SYNDAX PHARMACEUTICALS, INC. Common Stock (par value $0.0001 per share) SALES AGREEMENTSales Agreement • March 24th, 2021 • Syndax Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledMarch 24th, 2021 Company Industry JurisdictionSyndax Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cowen and Company, LLC (“Cowen”), as follows: